• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IXC

INVEX THERAPEUTICS LTD - Charts / Financials

31.9% ! 12.0¢
Market Cap $6.839M  !
Healthcare Biotechnology
Add to My Watchlist

Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical... Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. Our primary focus is on the orphan disease Idiopathic Intracranial Hypertension (IIH), a large and growing market opportunity with no regulatory cleared treatmentsMore

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.56pm 12/06/2026 (20 minute delay) ?
Day
Open 11.0¢   Day High 12.0¢   Day Low 11.0¢
Daily Volume 15609
Bids   Sellers
Number Price Volume   Number Price Volume
0 12.0¢ 17   0 13.0¢ 123934

Directors & Senior Management

Mr. David Colin Wheeler Non-Executive Director
Mr. Simon Llewellyn Owen Non-Executive Director
Mr. Timothy Ryan Slate Company Secretary
Prof. Warren John Harding Non-Executive Director

Data source: ADVFN

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
12.0¢ 		Change
0.029(31.9%) 		Mkt cap ! $6.839M
Open High Low Volume
11.0¢ 12.0¢ 11.0¢ 15.60K

Buyers (Bids)

Vol. Price($)
17 12.0¢
 

Sellers (Offers)

Price($) Vol.
13.0¢ 123934
Last trade - 15.56pm 12/06/2026 (20 minute delay) ?

Top Stories

Altitude Minerals kicks off drilling at Byrock copper-gold project

Altitude Minerals is testing a number of compelling RC drill targets recently confirmed at the Byrock project in NSW.
HotCopper Highlights, Week 24: Defence stocks soar on drone pivot, lithium debate rages on Boresight's explosive ASX debut, ongoing lithium debate, rising interest in defence tech: all the themes dominating HotCopper discussion this week.
From the Wire: Make way for the 'MANGOS' as Wall Street's AI hype comes back to reality On this week’s HotCopper Wire, hosts Isaac McIntyre and Jonathon Davidson took a look at the wobble in Wall Street’s bullish AI hype, how much is really vibes-based over any real fundamental investing, and whether, above all that, the bumper CY26 IPO listings just ...
Dale Gillham: Has crypto lost its magic? Investors rethink 'digital gold' narrative Bitcoin and the crypto market built its reputation on a simple promise: buy and hold it, and eventually you’ll be rewarded, but right now, that belief is being tested. Following one of its biggest declines in recent years, roughly half of all Bitcoin holders are now sitting on a l...
Energy Transition Minerals uncovers new Kvanefjeld rare earth target Energy Transition Minerals has uncovered new Kvanefjeld rare earth targets with 10 new rare earth element (REE) zones.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.